Obesity is not associated with disease‐free interval, melanoma‐specific survival, or overall survival in patients with clinical stage IB‐II melanoma after SLNB-Reference-Cited by-同舟云学术

Obesity is not associated with disease‐free interval, melanoma‐specific survival, or overall survival in patients with clinical stage IB‐II melanoma after SLNB

Published:2021-06-04 Issue:4 Volume:124 Page:655-664
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Deckers Eric A.¹^ORCID,Kruijff Schelto¹,Bastiaannet Esther²,Ginkel Robert J.¹,Hoekstra‐Weebers Josette E. H. M.³⁴,Hoekstra Harald J.¹

Affiliation:

1. Department of Surgical Oncology, University Medical Center Groningen University of Groningen Groningen The Netherlands

2. Department of Surgical Oncology Leiden University Medical Center Leiden The Netherlands

3. Department of Research and Development, Wenckebach Institute, University Medical Center Groningen University of Groningen Groningen The Netherlands

4. Department of Research and Development Netherlands Comprehensive Cancer Organization Utrecht The Netherlands

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26555

Reference51 articles.

1. NKR Cijfers. Integraal Kankercentrum Nederland.https://www.iknl.nl/nkr-cijfers. Groningen. 2020.

2. Melanoma

3. Cancer statistics, 2020

4. Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Body Mass Index on Melanoma Biology, Immunotherapy Efficacy, and Clinical Outcomes: A Narrative Review;International Journal of Molecular Sciences;2024-06-11

2. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies;ESMO Open;2024-03

3. Thiazolidinedione enhances the efficacy of anti-PD-1 monoclonal antibody in murine melanoma;American Journal of Physiology-Endocrinology and Metabolism;2024-03-01